Related Experiment Video
Updated: Jun 3, 2025
08:12
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
5.4K
Rectal Cancer: Exploring Predictive Biomarkers Through Molecular Pathways Involved in Carcinogenesis.
Sheila Martins1, Pedro Veiga2, José Guilherme Tralhão2,3,4,5
1Portuguese Oncology Institute of Coimbra, 3000-075 Coimbra, Portugal.
Biology
|January 8, 2025
Summary
Colorectal cancer (CCR) was the second most common cancer in Europe in 2022. Early detection and prevention strategies are crucial for reducing the impact of this disease.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- Colorectal cancer (CCR) is a significant public health concern in Europe.
- In 2022, CCR ranked as the second most diagnosed cancer in the region, following breast cancer.
Purpose of the Study:
- To analyze the incidence and trends of colorectal cancer in Europe.
- To highlight the public health burden posed by colorectal cancer.
Main Methods:
- Epidemiological data analysis.
- Cancer incidence statistics review for European countries.
Main Results:
- Colorectal cancer (CCR) demonstrated the second highest incidence rate across Europe in 2022.
- Breast cancer was the only cancer with a higher incidence.
Conclusions:
- The high incidence of colorectal cancer (CCR) underscores the need for enhanced screening and prevention programs.
- Continued monitoring and research are essential to combat the burden of colorectal cancer in Europe.
Related Concept Videos
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K